Clinical Pharmacology

Intensity of statin therapy and muscle symptoms: a network meta-analysis of 153 000 patients
John W Davis, Susan C Weller

BMJ Open Jun 2021, 11 (6) e043714; DOI: 10.1136/bmjopen-2020-043714
Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study
Nadine Ezard, Brendan Clifford, Adrian Dunlop, Raimondo Bruno, Andrew Carr, Zhixin Liu, Krista J Siefried, Nicholas Lintzeris

BMJ Open May 2021, 11 (5) e044696; DOI: 10.1136/bmjopen-2020-044696
Injury Prevention and long-term Outcomes following Trauma—the IPOT project: a protocol for prospective nationwide registry-based studies in Norway
Jo Steinson Stenehjem, Olav Røise, Trond Nordseth, Thomas Clausen, Bård Natvig, Svetlana O Skurtveit, Torsten Eken, Thomas Kristiansen, Jon Michael Gran, Leiv Arne Rosseland

BMJ Open May 2021, 11 (5) e046954; DOI: 10.1136/bmjopen-2020-046954
Fall incidents in nursing home residents: development of a predictive clinical rule (FINDER)
Vanja Milosevic, Aimee Linkens, Bjorn Winkens, Kim P G M Hurkens, Dennis Wong, Brigit P C van Oijen, Hugo M van der Kuy, Carlota Mestres-Gonzalvo

BMJ Open May 2021, 11 (5) e042941; DOI: 10.1136/bmjopen-2020-042941
Provider variability in the intraoperative use of neuromuscular blocking agents: a retrospective multicentre cohort study
Friederike C Althoff, Xinling Xu, Luca J Wachtendorf, Denys Shay, Maria Patrocinio, Maximilian S Schaefer, Timothy T Houle, Philipp Fassbender, Matthias Eikermann, Karuna Wongtangman

BMJ Open Apr 2021, 11 (4) e048509; DOI: 10.1136/bmjopen-2020-048509
Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study
Jan Wolff, Gudrun Hefner, Claus Normann, Klaus Kaier, Harald Binder, Katharina Domschke, Christoph Hiemke, Michael Marschollek, Ansgar Klimke

BMJ Open Apr 2021, 11 (4) e045276; DOI: 10.1136/bmjopen-2020-045276
From hospitalisation to primary care: integrative model of clinical pharmacy with patients implanted with a PICC line—research protocol for a prospective before–after study
Alix Marie Pouget, Elodie Civade, Philippe Cestac, Charlotte Rouzaud-Laborde

BMJ Open Apr 2021, 11 (4) e039490; DOI: 10.1136/bmjopen-2020-039490
Predictors of controlled prescription drug non-medical and lifetime use among patients accessing public mental health services in Uganda: a cross-sectional study
Pakoyo Fadhiru Kamba, John Mulangwa, Peter Kageni, Sulah Balikuna, Allan Kengo, Brian Byamah Mutamba, Nelson Sewankambo, Richard Odoi Adome, Pauline Byakika-Kibwika

BMJ Open Mar 2021, 11 (3) e037602; DOI: 10.1136/bmjopen-2020-037602
How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools
Elvira D'Andrea, Lydia Vinals, Elisabetta Patorno, Jessica M. Franklin, Dimitri Bennett, Joan A. Largent, Daniela C. Moga, Hongbo Yuan, Xuerong Wen, Andrew R. Zullo, Thomas P. A. Debray, Grammati Sarri

BMJ Open Mar 2021, 11 (3) e043961; DOI: 10.1136/bmjopen-2020-043961
Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study
Caroline Krüger, Ingmar Schäfer, Hendrik van den Bussche, Horst Bickel, Angela Fuchs, Jochen Gensichen, Hans-Helmut König, Wolfgang Maier, Karola Mergenthal, Steffi G Riedel-Heller, Gerhard Schön, Siegfried Weyerer, Birgitt Wiese, Wolfgang von Renteln-Kruse, Claudia Langebrake, Martin Scherer

BMJ Open Mar 2021, 11 (3) e044230; DOI: 10.1136/bmjopen-2020-044230

Main menu

Clinical Pharmacology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Clinical Pharmacology

Pages